-
公开(公告)号：US10543239B2
公开(公告)日：2020-01-28
申请号：US14983827
申请日：2015-12-30
发明人： Remy Burcelin , Didier Carcano , Pierre Desreumaux , Sampo Lahtinen , Nina Rautonen , Heli Putaala , Kirsti Tiihonen , Rodolphe Barrangou
IPC分类号： A61K35/747 , A61K35/745 , A61K35/74 , A61K35/00
摘要： The invention relates to use of a bacterium selected from a lactic acid bacterium, a Bifidobacterium or a mixture of any thereof for treating metabolic endotoxemia, inhibiting bacterial translocation and regulating lipid absorption in a mammal.
-
公开(公告)号：US20210322491A1
公开(公告)日：2021-10-21
申请号：US17180028
申请日：2021-02-19
发明人： Remy Burcelin , Didier Carcano , Sampo Lahtinen
IPC分类号： A61K35/745 , A61K31/155 , A61K35/747 , A61K45/06 , A23L33/135 , A61P5/50 , A61P3/04 , A23C9/123 , A61K31/715
摘要： This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.
-
3.发明申请公开(公告)号：US20180036355A1
公开(公告)日：2018-02-08
申请号：US15624083
申请日：2017-06-15
发明人： PIERRE DESREUMAUX , Didier Carcano
IPC分类号： A61K35/747 , G01N33/74 , A23K10/18 , G01N33/50 , A23L33/135 , C12R1/23 , C12Q1/68
CPC分类号： A61K35/747 , A23C9/1234 , A23C9/152 , A23K10/18 , A23L2/52 , A23L33/135 , A23V2002/00 , A23Y2220/03 , A61K35/744 , A61K35/745 , A61K2035/115 , C12Q1/6876 , C12Q2600/136 , C12Q2600/158 , C12R1/23 , G01N33/5023 , G01N33/74 , G01N33/948 , G01N33/9486 , G01N2333/726 , A61K2300/00
摘要： The invention proposes the use of at least one strain of Lactobacillus acidophilus to prepare a support administered to humans or animals with an analgesic purpose in the gastrointestinal system.
-
4.发明申请STRAIN OF LACTOBACILLUS ACIDOPHILUS HAVING ANALGESIC PROPERTIES IN THE GASTROINTESTINAL SYSTEM 审中-公开在胃肠道系统中具有毒性的乳酸杆菌酸菌菌株公开(公告)号：US20150023936A1
公开(公告)日：2015-01-22
申请号：US14506065
申请日：2014-10-03
发明人： Pierre Desreumaux , Didier Carcano
CPC分类号： A61K35/747 , A23C9/1234 , A23C9/152 , A23K10/18 , A23L2/52 , A23L33/135 , A23V2002/00 , A23Y2220/03 , A61K35/744 , A61K35/745 , A61K2035/115 , C12Q1/6876 , C12Q2600/136 , C12Q2600/158 , C12R1/23 , G01N33/5023 , G01N33/74 , G01N33/948 , G01N33/9486 , G01N2333/726 , A61K2300/00
摘要： The invention proposes the use of at least one strain of Lactobacillus acidophilus to prepare a support administered to humans or animals with an analgesic purpose in the gastrointestinal system.
摘要翻译： 本发明提出使用至少一种嗜酸乳杆菌菌株来制备在胃肠系统中以止痛目的施用于人或动物的支持物。
-
公开(公告)号：US20140348796A1
公开(公告)日：2014-11-27
申请号：US14455840
申请日：2014-08-08
发明人： Rémy Burcelin , Didier Carcano , Sampo Lahtinen
IPC分类号： A61K35/74 , A23C9/123 , A61K31/715
CPC分类号： A61K35/745 , A23C9/123 , A23L33/135 , A23V2002/00 , A23Y2300/21 , A61K31/155 , A61K31/715 , A61K35/747 , A61K45/06 , A61K2035/115 , A61K2300/00 , A61P3/04 , A61P5/50 , Y02A50/463 , A23V2200/328 , A23V2200/332 , A23V2200/324 , A23V2200/326
摘要： This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.
摘要翻译： 本发明涉及双歧杆菌的新用途（特别是但不仅限于益生菌双歧杆菌），以及含有它们的食品，饲料产品，膳食补充剂和药物制剂。 该细菌适用于治疗糖尿病（特别是2型糖尿病），肥胖症及相关病症，代谢综合征，胰岛素抵抗以及糖代谢障碍及其后果，降低组织炎症，治疗肝炎，肌炎和心血管疾病。
-
-
-
-
搜索结果
5 条记录 (耗时 0.016 秒)
